Skip to main content
SpringerLink
Log in

The inclusion of corticosteroids in treatment regimens for kawasaki disease: effect on coronary aneurysms

  • Clinical Trials Report
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Falcini F: Kawasaki disease. Current Opinion Rheumatol 2006, 18:33–38.

    Article  Google Scholar 

  2. Furusho K, Kamiya T, Nakano H, et al.: High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984, 2:1055–1058.

    Article  PubMed  CAS  Google Scholar 

  3. Hoffman JI: Do we have a gold standard yet? J Am Coll Cardiol 2004, 43:662–664.

    Article  PubMed  Google Scholar 

  4. Burns JC, Capparelli EV, Brown JA, et al.: Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 1998, 17:1144–1148.

    Article  PubMed  CAS  Google Scholar 

  5. Burns JC, Mason WH, Hauger SB, et al.: Infliximab treatment for refractory Kawasaki syndrome. J Pediatr 2005, 146:662–667.

    Article  PubMed  CAS  Google Scholar 

  6. Newburger JW, Takahashi M, Gerber MA, et al.: Diagnosis, treatment and long-term management of Kawasaki Disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004, 114:1708–1733.

    Article  PubMed  Google Scholar 

  7. Wright DA, Newburger JW, Baker A, Sundel RP: Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996, 128:146–149.

    Article  PubMed  CAS  Google Scholar 

  8. Sundel RP, Baker AL, Fulton DR, Newburger JW: Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J Pediatr 2003, 142:611–616.

    Article  PubMed  CAS  Google Scholar 

  9. Okada Y, Shinohara M, Koobayashi T, Inoue Y, et al.: Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. Pediatr 2003, 143:363–367.

    Article  CAS  Google Scholar 

  10. Kato H, Koike S, Yokoyama T: Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics 1979, 63:175–179.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Luis R. Espinoza MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Espinoza, L.R. The inclusion of corticosteroids in treatment regimens for kawasaki disease: effect on coronary aneurysms. Curr Rheumatol Rep 8, 290–291 (2006). https://doi.org/10.1007/s11926-006-0011-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-006-0011-9

Keywords

Search

Navigation